SPIA
ATYR

Steward Partners Investment Advisory’s aTyr Pharma ATYR Stock Holding History

Steward Partners Investment Advisory’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.7K Buy
19,600
+3,000
+18% +$1.96K ﹤0.01% 3657
2026
Q1 		$12.9K Buy
+16,600
New +$14K ﹤0.01% 3443

Other funds holding ATYR

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Steward Partners Investment Advisory's ATYR Position: Q2 2026 in Review

Steward Partners Investment Advisory increased its aTyr Pharma (ATYR) stake by 18% in Q2 2026, buying an estimated $1.96K and bringing the position to 19,600 shares worth $11.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3657.

Steward Partners Investment Advisory first reported a position in ATYR in Q1 2026 and has held it in 2 quarters since. The position peaked at $12.9K in Q1 2026. 90 funds tracked by Wall St. Rank hold ATYR as of Q2 2026.

  • Steward Partners Investment Advisory held 19,600 shares of aTyr Pharma worth $11.7K as of Q2 2026.
  • Steward Partners Investment Advisory bought 3,000 aTyr Pharma shares in Q2 2026, an estimated $1.96K.
  • aTyr Pharma made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #3657 holding.
  • Steward Partners Investment Advisory first reported a position in aTyr Pharma in Q1 2026 and has held it in 2 quarters since.
  • Steward Partners Investment Advisory's aTyr Pharma position peaked at $12.9K in Q1 2026.
  • 90 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.